WuXi XDC Cayman Inc 2268.HK
2268.HK
WuXi XDC Cayman Inc 2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 0241.HK
Alibaba Health Information Technology Limited 2607.HK
Shanghai Pharmaceuticals Holding Co., Ltd 3347.HK
Hangzhou Tigermed Consulting Co., Ltd. 1530.HK
3SBio Inc. 1099.HK
Sinopharm Group Co. Ltd. 3759.HK
Pharmaron Beijing Co., Ltd. 6127.HK
Joinn Laboratories(China)Co.,Ltd. 1093.HK
CSPC Pharmaceutical Group Limited
WuXi XDC Cayman Inc 2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 0241.HK
Alibaba Health Information Technology Limited 2607.HK
Shanghai Pharmaceuticals Holding Co., Ltd 3347.HK
Hangzhou Tigermed Consulting Co., Ltd. 1530.HK
3SBio Inc. 1099.HK
Sinopharm Group Co. Ltd. 3759.HK
Pharmaron Beijing Co., Ltd. 6127.HK
Joinn Laboratories(China)Co.,Ltd. 1093.HK
CSPC Pharmaceutical Group Limited
Performance
| Periode | 2268.HK | 2196.HK | 0241.HK | 2607.HK | 3347.HK | 1530.HK | 1099.HK | 3759.HK | 6127.HK | 1093.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 114.44 % | 69.96 % | 29.54 % | 10.54 % | 65.23 % | 136.45 % | 3.72 % | 88.98 % | 91.73 % | 57.55 % |
| YTD | 125.41 % | 73.18 % | 83.85 % | -4.78 % | 40.30 % | 373.70 % | -11.65 % | 75.34 % | 110.19 % | 89.20 % |
| 1Y | 187.58 % | 65.69 % | 50.25 % | -3.86 % | 13.86 % | 352.48 % | -8.81 % | 59.07 % | 108.56 % | 36.24 % |
| 3Y | 143.93 % | 22.98 % | 68.66 % | 7.94 % | -28.61 % | 365.90 % | 11.91 % | 2.15 % | -12.53 % | 7.62 % |
| 5Y | 143.93 % | -30.22 % | -70.98 % | -1.97 % | -65.38 % | 259.34 % | 15.85 % | -47.22 % | -62.68 % | -1.90 % |
| 10Y | 143.93 % | -6.64 % | 4.04 % | -33.92 % | -62.67 % | 217.75 % | -36.15 % | 24.17 % | -62.68 % | 135.48 % |
| From the beginning | 143.93 % | 120.00 % | 543.48 % | 1 028.30 % | -62.67 % | 202.46 % | -0.54 % | 24.17 % | -62.68 % | 1 203.80 % |